Pharmacy News Articles

▼ Show details

MDLinx Pharmacy helps physicians and healthcare professionals stay up to date with the latest pharmacy news articles and research, as well as pharmacy jobs, conferences, and resources.

Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA Applied Health Economics and Health Policy, October 17, 2014    Clinical Article

2 Influence of caffeine and hyaluronic acid on collagen biosynthesis in human skin fibroblasts Full Text Drug Design, Development and Therapy, October 17, 2014    Clinical Article

3 Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naive patients with gastroesophageal reflux disease: a post hoc analysis of two study populations Full Text BMC Gastroenterology, October 17, 2014    Clinical Article

4 Effect of Nicorandil in patients with heart failure: A systematic review and meta-analysis Cardiovascular Therapeutics, October 17, 2014    Evidence Based Medicine    Review Article    Clinical Article

5 Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12 Journal of Clinical Oncology, October 17, 2014    Clinical Article

6 Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients Clinical Infectious Diseases, October 17, 2014    Clinical Article

7 A randomized, open-label clinical study of combined pegylated interferon alfa-2a (40KD) and entecavir treatment for hepatitis B E antigen-positive chronic hepatitis B Clinical Infectious Diseases, October 17, 2014    Clinical Article

8 Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial The Lancet Oncology, October 17, 2014    Clinical Article

9 Aqueous extract of Rosmarinus officinalis l. inhibits neutrophil influx and cytokine secretion Phytotherapy Research, October 17, 2014    Clinical Article

10 FDA approves Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF) in the United States Full Text Roche, October 17, 2014

11 Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286 The Journal of Infectious Diseases, October 17, 2014    Clinical Article

12 Sarepta Therapeutics announces Eteplirsen demonstrates continued stability on walking test through 120 weeks in phase IIb study in Duchenne muscular dystrophy Full Text Sarepta Therapeutics, October 17, 2014

13 Penicillin-binding proteins: evergreen drug targets Current Opinion in Pharmacology , October 17, 2014    Clinical Article

14 Phase I study of 30-minute infusion of carfilzomib as single agent or in combination with low-dose dexamethasone in patients with relapsed and/or refractory multiple myeloma Journal of Clinical Oncology, October 17, 2014    Clinical Article

15 Hyaluronidase, phospholipase A2 and protease inhibitory activity of plants used in traditional treatment of snakebite-induced tissue necrosis in Mali, DR Congo and South Africa Journal of Ethnopharmacology , October 17, 2014    Clinical Article

16 The antidepressant treatment response index as a predictor of reboxetine treatment outcome in major depressive disorder Clinical EEG and Neuroscience, October 17, 2014    Clinical Article

17 Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: Impact of HIV and antiretroviral therapy Clinical Infectious Diseases, October 17, 2014    Clinical Article

18 Sarepta therapeutics announces publication of Ebola and Marburg phase I clinical study results in antimicrobial agents and chemotherapy Full Text Sarepta Therapeutics, October 17, 2014

19 A randomized study of the relative pharmacokinetics, pharmacodynamics and safety of alirocumab, a fully human monoclonal antibody to PCSK9, after single subcutaneous administration at three different injection sites in healthy subjects Cardiovascular Therapeutics, October 17, 2014    Clinical Article

20 Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II Current Opinion in Pharmacology , October 17, 2014    Review Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Pharmacy

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close